Seattle Children's · 4 hours ago
Postdoctoral Fellow - Heczey Lab
Seattle Children's is a leading pediatric research center dedicated to improving the health and well-being of children. The post-doctoral associate will focus on developing synthetic gene expression switches to enhance the efficacy of CAR T cell therapies in overcoming tumor immune escape.
BiotechnologyHealth CareHospitalHospitality
Responsibilities
Develop synthetic gene expression switches to overcome immune escape of tumors
Design and conduct experiments related to the project with the help of the mentor and other team members
Analyze data and present results at weekly laboratory meetings and research seminars
Record details of experiments and findings in electronic laboratory notebook
Qualification
Required
Doctorate degree (PhD/DVM/MD) in Immunology, genetic engineering, or related fields
Experience using basic research techniques of specialty area
Preferred
Great fund of knowledge of tumor immunology principles
Understanding advanced genetic engineering techniques (transfection, retroviral / lentiviral transduction, transposition, CRISPR-Cas9)
Viral particle assembly
Advanced cloning methods
Expertise in functional characterization of CAR T cells
Excellent aseptic cell culture technique
Enthusiasm and a willingness to learn in a fast-pace, collaborative environment
Strong organizational skills, record keeping, and interpersonal communication skills (verbal and written)
Benefits
Medical, dental, and vision plans
403(b)
Life insurance
Paid time off
Tuition reimbursement
Company
Seattle Children's
Hope. Care. Cure. These three simple words capture what we are here to do.
H1B Sponsorship
Seattle Children's has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (40)
2024 (29)
2023 (34)
2022 (41)
2021 (20)
2020 (13)
Funding
Current Stage
Late StageTotal Funding
$0.72MKey Investors
Fund for Science and TechnologyScaleReadyHyundai Hope On Wheels
2025-08-27Grant
2025-01-08Grant· $0.12M
2024-08-28Grant· $0.4M
Leadership Team
Recent News
2025-10-30
2025-10-18
Company data provided by crunchbase